QIM
CPRX

Quantitative Investment Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Quantitative Investment Management’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-11,500
Closed -$25K – 487
2014
Q1 		$25K Buy
+11,500
New +$24K ﹤0.01% 517

Other funds holding CPRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
CCA
Catalyst Capital Advisors Huntington, New York $5.37B AUM 18.53% 1-Year Est. Return

Quantitative Investment Management's CPRX Position: Q2 2014 in Review

Quantitative Investment Management sold out of Catalyst Pharmaceutical (CPRX) in Q2 2014, closing a stake of 11,500 shares — an estimated $25K sold.

Quantitative Investment Management first reported a position in CPRX in Q1 2014 and held it in 1 quarter. The position peaked at $25K in Q1 2014. 47 funds tracked by Wall St. Rank hold CPRX as of Q2 2014.

  • Quantitative Investment Management reported no remaining Catalyst Pharmaceutical position as of Q2 2014 after selling out during the quarter.
  • Quantitative Investment Management sold 11,500 Catalyst Pharmaceutical shares in Q2 2014, an estimated $25K.
  • Quantitative Investment Management first reported a position in Catalyst Pharmaceutical in Q1 2014 and held it in 1 quarter.
  • Quantitative Investment Management's Catalyst Pharmaceutical position peaked at $25K in Q1 2014.
  • 47 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2014.

Based on Quantitative Investment Management's 13F filing for Q2 2014, filed 8 Aug 2014.